Metalyse (tenecteplase) 8000 units (40 mg) and 10000 units (50 mg) powder and solvent for solution for injection: temporary supply shortage

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Metalyse
Active substance
tenecteplase
Therapeutic area (MeSH)
Myocardial Infarction
Procedure number
EMEA/H/C/000306
Regulatory outcome
Maintenance
DHPC type
Medicine shortage
Human ATC code
B01AD11
Dissemination date
23/09/2022

How useful was this page?

Add your rating